Comparison of germline and somatic structural variants in cancers reveal systematic differences in variant generating and selection processes.

Autor: Chukwu W; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Lee S; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Crane A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Zhang S; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Webster S; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Mittra I; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Imielinski M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; New York Genome Center, New York, NY, USA; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA; Department of Pathology and Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA., Beroukhim R; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Dubois F; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin; Humboldt-Universität zu Berlin, Institute of Pathology., Dalin S; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jun 18. Date of Electronic Publication: 2024 Jun 18.

A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study).

Autor: Ostwal V; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Ramaswamy A; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Bhargava P; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Srinivas S; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Mandavkar S; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Chaugule D; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Peelay Z; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Baheti A; Department of Radiodiagnosis, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Tandel H; Translational Research Lab, Tata Memorial Centre, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Homi Bhabha National Institute, Mumbai, India., Jadhav VK; Translational Research Lab, Tata Memorial Centre, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Homi Bhabha National Institute, Mumbai, India., Shinde S; Translational Research Lab, Tata Memorial Centre, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Homi Bhabha National Institute, Mumbai, India., Jadhav S; Department of Clinical Pharmacology, Tata Memorial Centre, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Navi Mumbai, India., Gota V; Department of Clinical Pharmacology, Tata Memorial Centre, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Navi Mumbai, India., Mittra I; Professor Emeritus Department of Surgical Oncology, Tata Memorial Centre, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Homi Bhabha National Institute, Kharghar, Mumbai, Navi Mumbai, 410 210, India. indraneel.mittra@gmail.com.

Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2022 Nov 13; Vol. 40 (1), pp. 17. Date of Electronic Publication: 2022 Nov 13.

Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.

Autor: Raghuram GV; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Pal K; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Sriram G; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Khan A; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Joshi R; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Jadhav V; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Shinde S; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Shaikh A; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Rane B; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Kangne H; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Mittra I; Translational Research Laboratory, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India.

Publikováno v: PloS one [PLoS One] 2024 Feb 12; Vol. 19 (2), pp. e0298042. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).

Cell-free chromatin particles released from dying cancer cells activate immune checkpoints in human lymphocytes: implications for cancer therapy.

Autor: Shabrish S; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Pal K; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Khare NK; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Satsangi D; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Pilankar A; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Jadhav V; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Shinde S; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Raphael N; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Sriram G; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Lopes R; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Raghuram GV; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Tandel H; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Mittra I; Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.; Homi Bhabha National Institute, Mumbai, India.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jan 11; Vol. 14, pp. 1331491. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2023).

In Utero Exposure to Methyl Isocyanate in the Bhopal Gas Disaster: Evidence of Persisting Hyperactivation of Immune System Two Decades Later

Autor: Mishra, P. K., Dabadghao, S., Modi, G. K., Desikan, P., Jain, A., Mittra, I., Gupta, D., Chauhan, C., Jain, S. K., Maudar, K. K.

Publikováno v: Occupational and Environmental Medicine, 2009 Apr 01. 66(4), 279-279.

Externí odkaz: https://www.jstor.org/stable/27733114